Skip to Main Content

Paper Details

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
Neurobiol Dis
9
2023
Author NameAffiliation
Jan St??hr
Virginia M-Y LeeCenter for Neurodegenerative Disease Research (CNDR), Institute on Aging, Perelman School of Medicine, University of Pennsylvania
  • 1 - 2

Datasets

Release 1.2